DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 4,767,612
|Title:||Triamcinolone acetonide for the treatment of allergic rhinitis|
|Abstract:||Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration from a nasal aerosol dispenser an effective amount of micronized triamcinolone acetonide suspended in dichlorodifluoromethane into the nasal cavity of a patient suffering from allergic rhinitis.|
|Inventor(s):||Hagen; Nicholas S. (Doylestown, PA), Lamon; Kim D. (Maple Glen, PA)|
|Assignee:||Rorer Pharmaceutical Corporation (Fort Washington, PA)|
1. A method for the control and treatment of allergic rhinitis in a patient having the symptoms of rhinorrhea, nasal itching, sneezing, congestion and postnasal drip
comprising the administration into the nasal cavity of said patient a nasal spray from an aerosol dispenser, said nasal spray consisting essentially of by weight:
3.75 to 30.0 mg of micronized triamcinolone acetonide;
123.75 to 97.5 mg of anhydrous ethanol;
9.75 gm of dichlorodifluoromethane; and
0 to 10 mg of sorbitan trioleate.
2. A method for the control and treatment of allergic rhinitis according to claim 1 wherein the administration of said nasal spray into the nasal cavity of said patient comprises the delivery of a daily dose of 200 to 1,600 mcg of micronized triamcinolone acetonide.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally: